Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001668397-24-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-27 | 2024-02-23+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $401.07 | -156.9K | 5.23M | -3% | -$62.94M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | S | D | 100,000 | $400.32 | 5,289,947 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $396.15 to $402.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2024-02-26 | S | D | 56,928 | $402.38 | 5,233,019 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $397.98 to $405.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |